Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for Hepatitis C infection

Journal of Psychosomatic Research

Volumn 77, Issue 2, 2014, Pages 109-115

  Mahajan, Sudhir ^a   Avasthi, Ajit ^a   Grover, Sandeep ^a   Chawla, Yogesh K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Depression; Interferon; Symptom profile

Indexed keywords

PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ANEMIA; ANTIVIRAL THERAPY; APPETITE DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; EMOTION; ENERGY; FATIGUE; FEMALE; HEPATITIS C; HUMAN; IRRITABILITY; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PATIENT HEALTH QUESTIONNAIRE; PATIENT HEALTH QUESTIONNAIRE 9; PHENOMENOLOGY; PLEASURE; PRESCRIPTION; PSYCHOSOCIAL WITHDRAWAL; RISK FACTOR; SLEEP DISORDER; THYROID DISEASE; VIRUS LOAD; WORK DISABILITY;

DEPRESSION; INTERFERON; SYMPTOM PROFILE;

ADULT; ANTIVIRAL AGENTS; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; INCIDENCE; INTERFERON-ALPHA; MALE; MIDDLE AGED; PERSONALITY INVENTORY; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECOMBINANT PROTEINS; RIBAVIRIN; SEVERITY OF ILLNESS INDEX;

EID: 84905035980     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2014.05.008     Document Type: Article

References (37)

1. Miyaoka H, Otsubo T, Kamijima K, et al. Depression from interferon therapy in patients with hepatitis C [letter]. Am J Psychiatry 1999, 156:1120.
2. Schaefer M, Ertgelbrecht MA, Gut O, et al. Interferon alpha (IFNα) and psychiatric syndromes: a review. ProgNeuropsychopharmacolBiol. Psychiatry 2002, 26:731-746.
3. Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001, 344:961-966.
4. Hauser P, Khosla J, Aurora H, et al. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 2002, 7:942-947.
5. Dieperink E, Ho SB, Thuras P, et al. A prospective study of neuropsychiatric symptoms associated with interferon-α-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003, 44:104-112.
6. Renault PF, Hoofnagle JH, Park Y, et al. Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 1987, 147:1577-1580.
7. Castera L, Zigante F, Bastie A, et al. Incidence of interferon alfa-induced depression in patients with chronic hepatitis C. Hepatology 2002, 35:978-979.
8. Kraus MR, Schafer A, Faller H, et al. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 2003, 64:708-714.
9. Schäfer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003, 37:443-451.
10. Reichenberg A, Gorman JM, Dieterich DT Interferon induced depression and cognitive impairment in hepatitis C virus patients: a 72week prospective study. AIDS 2005, 19:S174-S178.
11. Scalori A, Pozzi M, Bellia V, et al. Interferon-induced depression: prevalence and management. Dig Liver Dis 2005, 37:102-107.
12. Dan AA, Martin LM, Crone C, et al. Depression, anemia and health-related quality of life in chronic hepatitis C. J Hepatol 2006, 44:491-498.
13. Quarantini LC, Bressan RA, Galvao A, et al. Incidence of psychiatric side effects during pegylated interferon-α retreatment in nonresponder hepatitis C virus-infected patients. Liver Int 2007, 27:1098-1102.
14. Lotrich FE, Rabinovitz M, Gironda P, et al. Depression following pegylated interferon-alpha: characteristics and vulnerability. J Psychosom Res 2007, 63:131-135.
15. Castellvi P, Navinés R, Gutierrez F, et al. Pegylated interferon and ribavirin-induced depression in chronic hepatitis C: role of personality. J Clin Psychiatry 2009, 70:817-828.
16. Udina M, Castellví P, Moreno-España J, et al. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 2012, 73:1128-1138.
17. Malaguarnera M, Laurino A, DiFazio I, et al. Neuropsychiatric effects and type of IFN-a in chronic hepatitis C. J Interferon Cytokine Res 2001, 21:273-278.
18. Lieb K, Engelbrecht MA, Gut O, et al. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNa): results from a prospective study. Eur Psychiatry 2006, 21:204-210.
19. Loftis JM, Patterson AL, Wilhelm CJ, McNett H, Morasco BJ, Huckans M, et al. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study. J Psychosom Res 2013, 74:57-63.
20. Sheehan DV, Lecrubier Y, Harnett-Sheehan K, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59:22-33.
21. Spitzer RL, Kroenke K, Williams JB Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders Patient Health Questionnaire. JAMA 1999, 282:1737-1744.
22. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
23. Mahajan S, Avasthi A, Grover S, Chawla Y. Incidence of depression with combination of pegylated interferon-alpha and ribavirin therapy in patients with HCV infection. Psychosomatics & Psychotherapeutics (in press).
24. Raison CL, Borisov AS, Woolwine BJ, et al. Interferon-α effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry 2010, 15:535-547.
25. Galvão-de Almeida A, Quarantini LC, Tartaglioni AG, Lyra AC, Parise CL, Paraná R, et al. Serotonin-1A receptor CC genotype is associated with persistent depression related to interferon-alpha in hepatitis C patients. Gen Hosp Psychiatry 2014, 36:255-260.
26. Hou XJ, Xu JH, Wang J, Yu YY Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials?. PLoS One Oct. 30 2013, 8:e76799.
27. Kraus MR, Schäfer A, Faller H, et al. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther 2002, 16:1091-1099.
28. Cotler SJ, Wartelle CF, Larson AM, et al. Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. J Viral Hepat 2000, 7:211-217.
29. Freedland KE, Rich MW, Skala JA, et al. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003, 65:119-128.
30. Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24:1069-1078.
31. Bottomley A Depression in cancer patients: a literature review. Eur J Cancer Care (Engl) 1998, 7:181-191.
32. Richard IH Depression and apathy in Parkinson's disease. Curr Neurol Neurosci Rep 2007, 7:295-301.
33. Malaguarnera M, Di Fazio I, Restuccia S, et al. Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 1998, 37:93-97.
34. Hardy P Depressive disorders and interferon alpha. Gastroenterol Clin Biol 1996, 20:255-257.
35. Otsubo T, Miyaoka H, Kamijima K, et al. Depression during interferon therapy in chronic hepatitis C patients: a prospective study [in Japanese]. Seishin Shinkeigaky Zasshi 1997, 99:101-127.
36. Capuron L, Ravaud A Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state [letter]. N Engl J Med 1999, 340:1370.
37. Janssen HL, Brouwer JT, van der Mast RC, et al. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 1994, 21:241-243.